Skip to main content
. 2021 Nov 3;11:123–131. doi: 10.2147/PTT.S326121

Table 3.

PASI 90, PASI 100, and PGA Rates According to PGA Score at Time of Switching from Ustekinumab to Brodalumab

PGA at Treatment Switch PASI 90 Week 36 PASI 100 Week 36 PGA Success Week 12 PGA Success Week 36
2 (n=53) 41 (77.4%) 27 (50.9%) 27 (50.9%) 27 (50.9%)
3 (n=49) 24 (49.0%) 16 (32.7%) 28 (57.1) 27 (55.1%)
4/5 (n=18) 6 (33.3%) 2 (11.1%) 5 (27.8%) 6 (33.3%)

Abbreviations: PGA, physician’s global assessment; PASI, psoriasis area and severity index.